We noticed that high CMTM6 expression in ovarian serous adenocarcinoma was linked to preferable OS and progression-free survival (PFS), but in ovarian endometrioid adenocarcinoma, high-expressed CMTM6 only exhibited decent OS (Figure 3D). The gene discussed is CMTM6; the disease is ovarian serous adenocarcinoma.